These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

295 related articles for article (PubMed ID: 33539852)

  • 81. Immunoliposomes for cancer therapy.
    Kontermann RE
    Curr Opin Mol Ther; 2006 Feb; 8(1):39-45. PubMed ID: 16506524
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Towards clinical translation of ligand-functionalized liposomes in targeted cancer therapy: Challenges and opportunities.
    Belfiore L; Saunders DN; Ranson M; Thurecht KJ; Storm G; Vine KL
    J Control Release; 2018 May; 277():1-13. PubMed ID: 29501721
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Delivery of therapeutics for deep-seated ocular conditions - status quo.
    Nguyen H; Eng S; Ngo T; Dass CR
    J Pharm Pharmacol; 2018 Aug; 70(8):994-1001. PubMed ID: 29675844
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Chitosan-reduced gold nanoparticles: a novel carrier for the preparation of spray-dried liposomes for topical delivery.
    Padamwar MN; Patole MS; Pokharkar VB
    J Liposome Res; 2011 Dec; 21(4):324-32. PubMed ID: 21623705
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Recent advance of nanoparticle-based topical drug delivery to the posterior segment of the eye.
    Wang Y; Xu X; Gu Y; Cheng Y; Cao F
    Expert Opin Drug Deliv; 2018 Jul; 15(7):687-701. PubMed ID: 29985660
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Intradermal and follicular delivery of adapalene liposomes.
    Kumar V; Banga AK
    Drug Dev Ind Pharm; 2016; 42(6):871-9. PubMed ID: 27031916
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Effective topical delivery systems for corticosteroids: dermatological and histological evaluations.
    Eroğlu İ; Azizoğlu E; Özyazıcı M; Nenni M; Gürer Orhan H; Özbal S; Tekmen I; Ertam İ; Ünal İ; Özer Ö
    Drug Deliv; 2016 Jun; 23(5):1502-13. PubMed ID: 25259424
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Topical Delivery of Fenoprofen Calcium via Elastic Nano-vesicular Spanlastics: Optimization Using Experimental Design and In Vivo Evaluation.
    Farghaly DA; Aboelwafa AA; Hamza MY; Mohamed MI
    AAPS PharmSciTech; 2017 Nov; 18(8):2898-2909. PubMed ID: 28429293
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Micro- and nanoparticles--medical applications.
    Jătariu A; Peptu C; Popa M; Indrei A
    Rev Med Chir Soc Med Nat Iasi; 2009; 113(4):1160-9. PubMed ID: 20191893
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Intranasal immunisation of mice against Streptococcus equi using positively charged nanoparticulate carrier systems.
    Figueiredo L; Cadete A; Gonçalves LM; Corvo ML; Almeida AJ
    Vaccine; 2012 Oct; 30(46):6551-8. PubMed ID: 22947139
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Mitochondria-targeting particles.
    Wongrakpanich A; Geary SM; Joiner ML; Anderson ME; Salem AK
    Nanomedicine (Lond); 2014 Nov; 9(16):2531-43. PubMed ID: 25490424
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Nanotechnology-based Drug Delivery Systems as Potential for Skin Application: A Review.
    Baveloni FG; Riccio BVF; Di Filippo LD; Fernandes MA; Meneguin AB; Chorilli M
    Curr Med Chem; 2021; 28(16):3216-3248. PubMed ID: 32867631
    [TBL] [Abstract][Full Text] [Related]  

  • 93. [Nanostructured liposomal systems as transport agents for anticancer drugs].
    Baryshnikov AIu
    Vestn Ross Akad Med Nauk; 2012; (3):23-31. PubMed ID: 22712271
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Insights on Oral Drug Delivery of Lipid Nanocarriers: a Win-Win Solution for Augmenting Bioavailability of Antiretroviral Drugs.
    Nabi B; Rehman S; Baboota S; Ali J
    AAPS PharmSciTech; 2019 Jan; 20(2):60. PubMed ID: 30623263
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Therapeutics and carriers: the dual role of proteins in nanoparticles for ocular delivery.
    Pescina S; Sonvico F; Santi P; Nicoli S
    Curr Top Med Chem; 2015; 15(4):369-85. PubMed ID: 25579343
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Trends in liposomal nanocarrier strategies for the oral delivery of biologics.
    Mühlberg E; Burtscher M; Umstätter F; Fricker G; Mier W; Uhl P
    Nanomedicine (Lond); 2021 Aug; 16(20):1813-1832. PubMed ID: 34269068
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Nanotechnologies for intranasal drug delivery: an update of literature.
    Lombardo R; Musumeci T; Carbone C; Pignatello R
    Pharm Dev Technol; 2021 Oct; 26(8):824-845. PubMed ID: 34218736
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Enhanced vaginal drug delivery through the use of hypotonic formulations that induce fluid uptake.
    Ensign LM; Hoen TE; Maisel K; Cone RA; Hanes JS
    Biomaterials; 2013 Sep; 34(28):6922-9. PubMed ID: 23769419
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Multifunctional, stimuli-sensitive nanoparticulate systems for drug delivery.
    Torchilin VP
    Nat Rev Drug Discov; 2014 Nov; 13(11):813-27. PubMed ID: 25287120
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Targeted drug-delivery approaches by nanoparticulate carriers in the therapy of inflammatory diseases.
    Ulbrich W; Lamprecht A
    J R Soc Interface; 2010 Feb; 7 Suppl 1(Suppl 1):S55-66. PubMed ID: 19940000
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.